Top Markets
#1 Asteroid Shiba Asteroid Shiba +107,904.87%
#2 Moonriver Moonriver +162.76%
#3 inSure DeFi inSure DeFi +124.65%
#4 Lorenzo stBTC Lorenzo stBTC +78.86%
#5 Metis Metis +60.18%
#6 SOON SOON +44.13%
#7 tomiNet tomiNet +41.49%
#8 Sapien Sapien +34.55%
#9 Audius Audius +32.07%
#10 ZetaChain ZetaChain +20.94%
Coin of the day
Asteroid Shiba Asteroid Shiba
Settings
Language
ENGLISH
Currency
USD
Theme
Malin Corporation plc Malin Corporation plc

Malin Corporation plc

MLC
Rank in Stocks #20971
Malin Corporation plc, through its subsidiaries, operates in the life sciences... Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It offers life-saving cell and gene therapies for patients with high unmet medical need; medicines to address unmet needs in cancer, infection, and autoimmune diseases; and treatment of recurrent vulvovaginal candidiasis, an unmet need in women's health and onychomycosis or fungal nail infection. The company also provides drugs for protein misfolding diseases; and platform to distinguish disease-driving bacteria from the intestinal microbiota, as well as UV-light disinfection technology solutions. In addition, it provides company secretarial services. Malin Corporation plc was incorporated in 2014 and is headquartered in Dublin, Ireland.
Share Price
$9.13
Market Cap
$39.27K
Change (1 day)
0.00%
Change (1 year)
-11.76%
Country
IE
Trade Malin Corporation plc (MLC)

Category

Healthcare
P/S ratio for Malin Corporation plc (MLC)
P/S ratio as of April 2026 TTM: 0.00
According to Malin Corporation plc latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.00. At the end of 2023 the company had a P/S ratio of 0.00.
P/S ratio history for Malin Corporation plc from 2015 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
2026 (TTM) 0.00 0.00%
2024 0.00 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 -100.00%
2020 4.59 -23.13%
2019 5.97 -0.70%
2018 6.01 -26.94%
2017 8.23 -27.92%
2016 11.42 -10.39%
2015 12.74 0.00%
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPSEY.US
3.71 -
FR
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MKGAF.US
2.40 -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
TAK.US
2.00 -
JP
Zoetis Inc. Zoetis Inc.
Zoetis Inc.
ZTS.US
5.40 -
US
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
7.06 -
IN